Gap19, CAS No.1507930-57-5

CAS: 1507930-57-5 Cat. No.: G287766 분자식: C55H96N14O13 분자량: 1161.44 PubChem CID: 91691126
주문 가능
등급 & 순도 ≥98%
★
크기
USA
독일 (EU)*
가격
수량
5mg
G287766-5mg
3 재고 있음
—

US$251.90

US$344.90
저장 US$93.00 (26.96%)
25mg
G287766-25mg
3 재고 있음
—

US$926.90

US$1,202.90
저장 US$276.00 (22.94%)
100mg
G287766-100mg
2 재고 있음
—

US$2,942.90

US$3,434.90
저장 US$492.00 (14.32%)
Enter a quantity for the sizes you want to add.
🧪
이 등급을 선택하는 이유

≥98% 최소한의 기준선 간섭이 필요한 민감한 크로마토그래피 및 분석 워크플로우용.

🌡

보관 및 배송

Store at -20°C Ice chest + Ice pads 출고. 정확한 사양은 로트별 COA를 확인하세요.

📋

품질 문서

SDS, COA, 데이터시트, 사양서를 다운로드할 수 있습니다. 로트별 COA는 로트 번호 조회를 통해 확인할 수 있습니다.

📚

문헌적 근거

크로마토그래피, 유기 합성 및 교차 커플링 반응 분야의 동료 심사 논문 0편에서 인용되었습니다.

사양

Product Name
Gap19, CAS No.1507930-57-5
사양 및 순도
≥98%
생화학 및 생리적 메커니즘
Selective connexin 43 (Cx43) hemichannel blocker; has no effect on gap junction coupling or Panx-1 channels. Reduces mitochondrial potassium influx in cardiomyocytes and attenuates glutamate-triggered ATP release in primary astrocytes. Modestly reduces in
시퀀스
KQIEIKKFK
작업 유형
INHIBITOR
CAS
1507930-57-5
분자 유형
Small molecule
보관 및 배송
보관 조건
Store at -20°C
배송
Ice chest + Ice pads

문서

📋 안전 데이터 시트(SDS)

위험성, 취급, 보관 및 규제 준수를 포괄하는 종합 문서.

<<<<<<< HEAD SDS 다운로드 → ======= SDS 다운로드 → >>>>>>> release248-p3

✅ 분석 성적서(COA)

로트별 품질 데이터. 로트 번호를 입력하여 정확한 COA를 확인하세요.

COA 조회 →

📊 데이터시트

제품 사양 및 응용 분야에 대한 빠른 참조 요약.

데이터시트 보기 →

🔬 사양서

이 등급의 전체 품질 특성 및 합격 기준.

사양서 보기 →

고급 데이터

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganic acids and derivatives
분류Carboxylic acids and derivatives
SubclassAmino acids, peptides, and analogues
Intermediate Tree Nodes Peptides
Direct ParentOligopeptides
Alternative Parents Phenylalanine and derivatives  Glutamine and derivatives  Glutamic acid and derivatives  Isoleucine and derivatives  N-acyl-L-alpha-amino acids  Alpha amino acid amides  Amphetamines and derivatives  Medium-chain fatty acids  Amino fatty acids  Branched fatty acids  N-acyl amines  Dicarboxylic acids and derivatives  Secondary carboxylic acid amides  Primary carboxylic acid amides  Amino acids  Carboxylic acids  Carbonyl compounds  Hydrocarbon derivatives  Monoalkylamines  Organic oxides  Organopnictogen compounds  
Molecular FrameworkAromatic homomonocyclic compounds
Substituents Alpha-oligopeptide - Phenylalanine or derivatives - Glutamine or derivatives - Glutamic acid or derivatives - Isoleucine or derivatives - N-acyl-alpha-amino acid - N-acyl-alpha amino acid or derivatives - N-acyl-l-alpha-amino acid - Alpha-amino acid amide - N-substituted-alpha-amino acid - Alpha-amino acid or derivatives - Amphetamine or derivatives - Medium-chain fatty acid - Branched fatty acid - Amino fatty acid - Fatty acyl - Dicarboxylic acid or derivatives - Monocyclic benzene moiety - N-acyl-amine - Fatty amide - Benzenoid - Fatty acid - Secondary carboxylic acid amide - Primary carboxylic acid amide - Amino acid - Amino acid or derivatives - Carboxamide group - Carboxylic acid - Organic nitrogen compound - Primary aliphatic amine - Carbonyl group - Organonitrogen compound - Organooxygen compound - Primary amine - Hydrocarbon derivative - Organic oxide - Amine - Organopnictogen compound - Organic oxygen compound - Aromatic homomonocyclic compound
설명This compound belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds.
External Descriptors Not available
3D 구조
상호 작용 화학 구조 모델





인증서(CoA, COO, BSE/TSE 및 분석 차트)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate Type날짜항목
I2207751I2207751Certificate of AnalysisJun 10, 2025 G287766
I2207752I2207752Certificate of AnalysisJun 10, 2025 G287766
I2207756I2207756Certificate of AnalysisJun 10, 2025 G287766
솔루션 계산기
리뷰

고객 리뷰

Application Protocols
  • Item-specific (from Product Data)
    • Not specified for this item; no tested applications or recommended dilutions are provided.
  • General guidance (not item-specific)
    • Establish assay-specific dose–response and time-course. Include appropriate negative/vehicle controls and, where relevant, orthogonal readouts (e.g., electrophysiology, dye uptake assays).
    • Filter-sterilize solutions if required by your workflow and sequence stability. Use low-binding plasticware to minimize adsorption for low-concentration work.
Biological Roles
  • Item-specific (from Product Data)
    • No biological role claims are specified for this item. Research use only.
  • General/literature context for the name “Gap19” (not item-specific)
    • The literature commonly refers to “Gap19” as a short peptide tool used to study connexin-mediated cell–cell communication, particularly in the context of hemichannels associated with connexin43. Such tools are exploited to dissect contributions of channel opening/closing to cellular signaling, ion homeostasis, and small-molecule exchange.
    • As a peptide probe, its biological effects, selectivity, and kinetics can depend on sequence, concentration, cell type, and experimental conditions. Verification of target engagement typically involves electrophysiological measures, dye permeability assays, or genetic controls.
    • Important caveat: precise sequence, modifications, and formulation control the observed biology; consult the item’s CoA and validate in your system. No medical or therapeutic claims are made; this product is for laboratory research use only.
Buffer Applications
  • Not typically applicable.
  • Rationale: This catalog entry is a small research peptide, not a buffering agent. It does not constitute a classical buffer system and is not used to set or maintain pH.
  • Practical note: Prepare and use in appropriate biological buffers (e.g., PBS, HEPES) suitable for your assay, ensuring compatibility with cells/tissues and with the peptide’s solubility and stability. Specific buffer recipes and pH ranges are application-dependent and not specified for this item.
Green Alternatives
  • Context
    • For a small research peptide, “green alternatives” relate more to handling and formulation than replacement by another solvent or reagent.
  • Practical sustainability considerations (general, not item-specific)
    • Diluent selection: Prefer aqueous buffers over organic solvents when solubility permits to minimize VOCs and hazardous waste.
    • Stock solution strategy: Use high-concentration stocks to reduce container count and cold-chain volume; aliquot to extend shelf life and reduce waste.
    • Packaging/waste: Consolidate orders to reduce cold-pack materials; recycle secondary packaging where supported.
    • Process choice: If synthesizing related peptides in-house, consider microwave-assisted SPPS, greener coupling reagents, and solvent recycling systems (literature practices), though this does not apply directly to the use of the catalogued item.
  • Alternatives within the research toolbox
    • Where the biological question allows, genetic or optogenetic approaches can complement or reduce reliance on repeated peptide dosing. Trade-offs include development time, specialized equipment, and different off-target profiles.
Pharmaceutical Uses
  • Item-specific (from Product Data)
    • No pharmacopeial status, formulation role, or excipient information is provided for this item.
  • General guidance (not item-specific)
    • This material is designated For research use only and is not intended for human or veterinary use, clinical diagnostics, or as a drug substance/excipient.
    • In preclinical research settings, bioactive peptides are sometimes used as tool compounds to probe mechanisms in vitro or in ex vivo models. Any formulation considerations (vehicle, tonicity adjusters, sterile filtration) are strictly for laboratory studies and must follow institutional approvals.
    • If translational formulation studies are performed in research contexts, critical specifications would include identity, purity, counterion content, endotoxin level, sterility, and stability-indicating methods—none of which are specified here and must be verified from the CoA/SDS for this specific item.
Physical Properties
  • Item-specific (from Product Data)
    • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Other specifications (mp/bp, density, solubility, logP, pKa, refractive index): Not specified for this item; refer to CoA/Spec Sheet.
  • General/literature context (not item-specific)
    • Short research peptides are typically obtained as amorphous white to off-white solids or lyophilized powders.
    • Solubility (literature, sequence-dependent): Many short peptides are soluble in water, aqueous buffers (e.g., PBS), or in DMSO if hydrophobic content is high. Adjusting pH or adding small amounts of organic cosolvent can aid dissolution.
    • Hygroscopicity: Peptides can be moderately hygroscopic; exposure to ambient moisture may affect handling and weigh-out.
    • Counterions/salt form: Peptide trifluoroacetate (TFA) salts are common; alternative counterions (e.g., acetate, HCl) may be used depending on synthesis and purification. The salt form can influence apparent mass and solubility (literature).
Quality and Grades
  • Item-specific (from Product Data)
    • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
  • How to interpret typical peptide grades (general, not item-specific)
    • Crude vs. purified: Research peptides are often supplied as purified materials with HPLC purity (e.g., >90–98% by analytical HPLC). Purity level impacts background effects and dose–response sharpness in cell assays.
    • Counterion content and residual solvents: TFA, water, and residual acetonitrile may be present from purification; high-quality grades report these values on the CoA.
    • Identity confirmation: Typically established by LC–MS and sometimes HRMS; amino acid analysis or sequencing can provide orthogonal confirmation. For bioactive peptides, correct terminal modifications (e.g., free amine/acid vs. acetyl/amidated) are critical.
    • Implications for use: Higher purity reduces confounding effects in sensitive biological readouts. If your work is quantitative, request or consult the CoA for exact purity, salt form, water content, and extinction coefficients (if applicable).
Reaction and Applications
  • Item-specific (from Product Data)
    • Manufacturer Applications: Not specified beyond listing; no item-specific application details provided.
  • General/literature context for a peptide named “Gap19” (not item-specific)
    • In the scientific literature, “Gap19” denotes a short peptide research tool frequently used to interrogate connexin hemichannel biology, often discussed in relation to connexin43. Researchers employ such peptides in cell culture and ex vivo tissue studies as chemical biology probes to modulate intercellular communication pathways.
    • Typical applications (literature): time-dependent exposure of cells or tissues to peptide solutions; assessments via dye uptake/release assays, electrophysiology, Ca2+ imaging, or biochemical readouts. Concentration and exposure schedules are highly system- and supplier-specific and should be validated empirically.
    • This catalogue item is a finished reagent rather than a synthetic building block; it is not typically used as a substrate, catalyst, or solvent in chemical reactions. Focus usage on biological assay design and compatibility with your model system, and always corroborate the precise sequence and formulation from the item’s CoA.
Reaction Conditions
  • Not applicable as a chemical reactant.
  • General laboratory use conditions for peptide tools (not item-specific; defer to your protocol)
    • Reconstitution: Typically in sterile water, buffer, or DMSO depending on solubility; prepare concentrated stocks and dilute into assay media shortly before use.
    • Exposure: In vitro applications often utilize time- and dose-dependent incubations; exact concentrations and durations are assay-specific and should be optimized empirically.
    • Compatibility: Maintain physiological pH and osmolality. Minimize organic solvent content in cell-based systems. Avoid repeated freeze–thaw of working stocks.
    • Note: No item-specific concentration, incubation time, or yield data are provided. Consult primary literature and validate in your system.
Safety and Handling
  • Item-specific (from Product Data)
    • GHS Classification / Signal Word / H-Statements / Pictograms: Not specified for this item; refer to SDS.
    • Storage Conditions: Store at -20°C.
    • Shipping: Shipped in ice chest + ice pads.
  • General safety guidance (not item-specific; always defer to SDS)
    • PPE: Laboratory coat, gloves (nitrile), and safety glasses as minimum. Avoid inhalation of particulate; handle powders in a fume hood or ventilated enclosure.
    • Handling: Allow vials to equilibrate to room temperature in a desiccated environment before opening to minimize condensation. Avoid repeated freeze–thaw of solutions; aliquot upon first reconstitution.
    • Incompatibilities (general for peptides): Strong oxidizers and extremes of pH can degrade peptides. Protect from light if chromophoric residues or modifications are present.
    • First-aid overview: If inhaled, move to fresh air; if on skin/eyes, rinse with water; if ingested, rinse mouth. Seek medical attention as per institutional protocols. Consult the SDS for definitive measures.
    • Waste: Dispose of peptide solutions and containers according to institutional and local regulations for chemical/biological research waste.
Solvent Selection
  • Item-specific (from Product Data)
    • No solvent recommendations are specified for this item; refer to CoA/Spec Sheet.
  • General guidance for small research peptides (literature, not item-specific)
    • Primary choices: Water or aqueous buffers (e.g., PBS, HEPES) are preferred when the sequence is moderately polar. For hydrophobic sequences, prepare a small DMSO stock (e.g., high mM), then dilute into buffer while keeping final DMSO ≤0.1–0.5% v/v for cell work.
    • pH effects: Adjusting pH toward net charge can enhance solubility (acidic pH for basic peptides, basic pH for acidic ones). Avoid prolonged exposure to extreme pH to limit degradation (deamidation, hydrolysis).
    • Order of operations: Add solvent gradually with gentle vortexing/sonication; avoid vigorous foaming. Filter sterilize through 0.22 μm if required by the application and sequence stability.
    • Comparison (general):
      • Water/buffer: biocompatible, ideal for immediate use; limited for highly hydrophobic peptides.
      • DMSO: excellent solvating power; monitor final % in biological systems.
      • Dilute HCl/NaOH: can assist initial dissolution; neutralize promptly after solubilization.
Storage and Reconstitution
  • Item-specific (from Product Data)
    • Storage: Store at -20°C.
    • Shipping: Ice chest + ice pads.
  • Additional guidance (general, not item-specific)
    • Handling unopened vials: Allow to warm to room temperature in a desiccator before opening to prevent condensation.
    • Reconstitution: Not specified for this item; refer to CoA/Spec Sheet. Common approaches include sterile water or buffer for polar sequences; or initial dissolution in DMSO for hydrophobic sequences, followed by dilution into aqueous media. If concentration is unknown, gravimetrically determine mass or use supplier’s fill information.
    • Aliquoting: Prepare single-use aliquots to avoid repeated freeze–thaw. Store aliquots at -20°C or lower, protected from light and moisture.
    • Stability: Working solutions are typically used the same day; short-term storage at 2–8°C may be possible depending on sequence and buffer. Long-term stability and freeze–thaw tolerance are sequence- and formulation-dependent and are not specified for this item; verify experimentally.
    • Always consult the product’s CoA/SDS for definitive instructions.
Structure and Identity
  • Item-specific (from Product Data)
    • SKU: G287766
    • Product Name: Gap19
    • CAS: 1507930-57-5
    • PubChem CID: 91691126
    • InChIKey: 138474 (as provided)
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • General/literature context (not item-specific)
    • The name “Gap19” is widely used in the literature for a short peptidic research tool derived from the intracellular loop of connexin proteins, commonly discussed in the context of connexin43 hemichannel studies. Exact sequence and salt/terminal modifications vary by supplier; consult the specific CoA for this item.
    • Structural features (typical for such peptides): a short linear peptide with amide bonds forming the backbone, side-chain functional groups spanning basic, acidic, and/or hydrophobic residues depending on the precise sequence and modifications.
    • 2D structure description (general peptide): a linear chain of α-amino acid residues connected by peptide bonds; potential N-/C-terminal capping and counterions may be present depending on the formulation (literature, not item-specific).
Synthetic Utility
  • Not typically applicable.
  • Rationale: This product is supplied as a finished peptide research reagent, not as a synthetic building block or catalyst. It is not generally used in bond-forming reactions or as a reagent in organic synthesis.
  • Related notes (general, not item-specific)
    • If derivatization is required for specialized studies (e.g., fluorescent labeling, biotinylation), users would normally obtain the appropriately modified peptide from custom synthesis, ensuring control over labeling site, purity, and counterion. Attempting post-purchase chemical modification without full specifications risks loss of activity and heterogeneity.
Target Specificity
  • Item-specific (from Product Data)
    • Not specified for this item; refer to CoA/Spec Sheet.
  • Important note: No claims regarding molecular targets, binding partners, or selectivity are made here beyond what appears in the Product Data. Users should consult the item’s documentation and validate specificity in their own assays.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.